![]() Sera Prognostics Sera Prognostics is a health diagnostic company that discovers, develops, and commercializes biomarker tests for the early prediction of preterm birth risk and other complications of pregnancy. | ![]() Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. | ||
Founding Date | Founding Date 2008 | Founding Date 2008 | Founding Date 2004 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Docklands, AU HQ Richmond, AU | Locations Salt Lake City, US HQ Brentwood, US | Locations Austin, US HQ San Carlos, US |
Employees | Employees 99715% increase | Employees 8713% increase | Employees 3,28211% increase |
Valuation ($) | Valuation ($) 324.4 m | Valuation ($) 236.2 m | Valuation ($) 15.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) $271.9m (FY, 2025) | Revenue (est.) $81k (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods $29.5m (FY, 2025) | Cost of goods $164k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $242.5m (FY, 2025) | Gross profit ($83k) (FY, 2025) | Gross profit N/A |
Net income | Net income $25.7m (FY, 2025) | Net income ($31.9m) (FY, 2025) | Net income ($208.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 250.3m | Total funding raised $ 154.1m |

Sera Prognostics is a health diagnostic company that discovers, develops, and commercializes biomarker tests for the early prediction of preterm birth risk and other complications of pregnancy.
View company
Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.
View company